Finance

Beta
Lists
8E8:FRA
Elicera Therapeutics AB
€0.24
+6.00%
(+0.014) 1D
Jun 5, 8:09:46 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8E8...
Open
€0.24
High
€0.24
Low
€0.24
Mkt. cap
202.76M
Avg. vol.
38.00
Volume
0.00
52-wk high
€0.67
52-wk low
€0.23
No. of employees
3
Open
€0.24
High
€0.24
Low
€0.24
Mkt. cap
202.76M
Avg. vol.
38.00
Volume
0.00
52-wk high
€0.67
52-wk low
€0.23
No. of employees
3
News stories
From sources across the web
About Elicera Therapeutics AB
CEO-
Employees3
Founded2014
Headquarters-
SectorBiotechnology
Websiteelicera.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.70M
7.91M
30.00K
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.59M
7.76M
7.16M
5.12M
Operating expense
5.59M
7.76M
7.16M
5.12M
Total operating expenses
5.59M
7.76M
7.16M
5.12M
Operating income
-2.89M
146.69K
-7.13M
-5.12M
Other non operating income
-
1.32K
-
-
EBT including unusual items
-2.73M
304.15K
-6.97M
-5.06M
EBT excluding unusual items
-2.73M
304.15K
-6.97M
-5.06M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.73M
304.15K
-6.97M
-5.06M
Net profit margin
-101.33%
3.85%
-23,219.94%
-
Earnings per share
-
-
-
-
Interest and investment income
164.29K
156.14K
169.41K
61.50K
Interest expense
-4.02K
-
-5.07K
-4.78K
Net interest expenses
160.27K
156.14K
164.34K
56.72K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.89M
149.63K
-7.13M
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer